This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


3cs6

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px <!-- The line below this paragraph, containing "STRUCTURE_3cs6", creates the "Structure Box" on the page. You may change the PDB parameter (which sets the PD...)
Line 1: Line 1:
-
[[Image:3cs6.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:3cs6.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_3cs6| PDB=3cs6 | SCENE= }}
{{STRUCTURE_3cs6| PDB=3cs6 | SCENE= }}
-
'''Structure-based design of a superagonist ligand for the vitamin D nuclear receptor'''
+
===Structure-based design of a superagonist ligand for the vitamin D nuclear receptor===
-
==Overview==
+
<!--
-
Vitamin D nuclear receptor (VDR), a ligand-dependent transcriptional regulator, is an important target for multiple clinical applications, such as osteoporosis and cancer. Since exacerbated increase of calcium serum level is currently associated with VDR ligands action, superagonists with low calcium serum levels have been developed. Based on the crystal structures of human VDR (hVDR) bound to 1alpha,25-dihydroxyvitamin D(3) and superagonists-notably, KH1060-we designed a superagonist ligand. In order to optimize the aliphatic side chain conformation with a subsequent entropy benefit, we incorporated an oxolane ring and generated two stereo diasteromers, AMCR277A and AMCR277B. Only AMCR277A exhibits superagonist activity in vitro, but is as calcemic in vivo as the natural ligand. The crystal structures of the complexes between the ligand binding domain of hVDR and these ligands provide a rational approach to the design of more potent superagonist ligands for potential clinical application.
+
The line below this paragraph, {{ABSTRACT_PUBMED_18420145}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 18420145 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_18420145}}
==About this Structure==
==About this Structure==
Line 46: Line 50:
[[Category: Zinc]]
[[Category: Zinc]]
[[Category: Zinc-finger]]
[[Category: Zinc-finger]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed May 28 09:23:47 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 20:38:11 2008''

Revision as of 17:38, 28 July 2008

Image:3cs6.png

Template:STRUCTURE 3cs6

Structure-based design of a superagonist ligand for the vitamin D nuclear receptor

Template:ABSTRACT PUBMED 18420145

About this Structure

3CS6 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Structure-based design of a superagonist ligand for the vitamin D nuclear receptor., Hourai S, Rodrigues LC, Antony P, Reina-San-Martin B, Ciesielski F, Magnier BC, Schoonjans K, Mourino A, Rochel N, Moras D, Chem Biol. 2008 Apr;15(4):383-92. PMID:18420145

Page seeded by OCA on Mon Jul 28 20:38:11 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/3cs6"
Personal tools